Olema director granted options for 29,500 shares
Olema Pharmaceuticals director Raman Prakash received a stock option grant for 29,500 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Olema Pharmaceuticals director Raman Prakash received a stock option grant for 29,500 shares of common stock. The option has an exercise price of $9.51 per share and expires on June 18, 2036. It was awarded as compensation rather than purchased on the open market.
The 29,500 underlying shares vest in 12 equal monthly installments starting on June 18, 2026, as long as Prakash continues in service through each vesting date. Any unvested portion will fully vest on the date of Olema’s next annual stockholder meeting if it is not already fully vested and he remains in service through that date.
Insider Trade Summary
Grant/Award: 29,500 shares
Grant/Award
1 txn
Insider
Raman Prakash
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 29,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 29,500 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 18, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
Option grant size: 29,500 options
Exercise price: $9.51 per share
Underlying shares: 29,500 shares
+3 more
6 metrics
Option grant size
29,500 options
Stock Option (right to buy) granted to director Raman Prakash
Exercise price
$9.51 per share
Conversion or exercise price of granted stock options
Underlying shares
29,500 shares
Common Stock underlying the stock option grant
Expiration date
June 18, 2036
Stock option expiration for the grant
Post-grant option holdings
29,500 options
Total derivative securities following the reported transaction
Monthly vesting schedule
12 monthly installments
Vesting measured from June 18, 2026 subject to continuous service
Key Terms
Stock Option (right to buy), exercise price, vest, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 9.5100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"The shares subject to the option vest in a series of 12 successive equal monthly installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"expiration_date: 2036-06-18T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
continuous service financial
"subject to the Reporting Person's continuous service through each applicable vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Olema Pharmaceuticals (OLMA) report for Raman Prakash?
Olema reported that director Raman Prakash received a grant of stock options for 29,500 shares of common stock. This was a compensation-related award, not an open-market purchase, and gives him the right to buy shares at a fixed exercise price.
What is the exercise price of Raman Prakash’s Olema Pharmaceuticals (OLMA) stock options?
The stock options granted to Raman Prakash have an exercise price of $9.51 per share. This means he can buy Olema common stock at $9.51 for each optioned share once those options have vested and before they expire.
When do Raman Prakash’s Olema Pharmaceuticals (OLMA) options vest?
The options vest in 12 equal monthly installments starting on June 18, 2026, subject to his continuous service. Any portion not vested by the next annual stockholder meeting will fully vest on that date, provided he remains in service through that vesting date.
When do Raman Prakash’s Olema Pharmaceuticals (OLMA) stock options expire?
The option award to Raman Prakash expires on June 18, 2036. He must exercise any vested options before this expiration date if he wants to purchase Olema common shares at the $9.51 exercise price provided by the grant.
Is Raman Prakash’s Olema Pharmaceuticals (OLMA) Form 4 a stock purchase or a grant?
The Form 4 shows a grant or award acquisition of stock options, coded as transaction type “A”. This reflects compensation in the form of options, not an open-market stock purchase or sale by Prakash in Olema’s common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates